its not about the "valuable" tech its about the working product. they might have set a prize for the trial tested product. who cares about the tech? your argument is flawed.
anyways i just repeated the $2-3 story as i wasnt the one who made that claim here. i mean think about the returns they would actually make. they bought their shares at 5 cents? i dont know exactly. 300 million for a trial tested device doesnt sound unrealistic for me. lets pull the taser example again... look at their market cap... its around a billion last time i checked and they have way more than a trial tested device...
News 
Market Data 
Discover 
